Abstract:Aim To explore the in vitro and in vivo angiogenic capacity and phenotypic properties about different clonal endothelial progenitor cell populations derived from human peripheral circulating blood. Methods Mononuclear cells were isolated by density-gradient centrifugation and incubated onto fibronectin-coated dishes in endothelial medium in the presence of vascular endothelial growth factor.The number of early clones was counted at 7 days and cells from another aliquot were cultivated continually until the late clones generated.Flow cytometry analysis was used to evaluate cells surface antigen expression and von willebrand factor(vWF),the endothelial cells marker was detected by indirect fluorescence staining.The capacities of in vitro and in vivo vascular genesis were assessed by plating cells onto collagen gels and implanting the cellularized gel into nude mice. Results Early clones failed to form second clone and were devoid of the capacity of in vitro and in vivo vascular genesis.Furthermore,cells derived from the early clones expressed mainly CD14 and CD45.In contrast to early clones,the late clones emerged until 21 to 28 days after cultivation and exhibited typically endothelial cells properties.Remarkably,cells originated from late clones had the ability to form second endothelial clones after replanted and generated tube-like structures when seeded onto collagen gels or transplanted into nude mice.In addition to the clearly morphological and functional differences,cells derived from late clones expressed obviously increased CD146(P<0.01) and reduced CD45 and CD14(P<0.001). Conclusions Under endothelial cultivating conditions,human peripheral blood mononuclear cells can generate early and late clones.Only cells originated from late clones exhibit double phenotypes of stem/progenitor and endothelial cells with the capacity of in vitro and in vivo vasculargenesis.

ESTABLISHMENT OF HIGH-THROUGHPUT TECHNICAL PLATFORM FOR TUMOR ANGIOGENESIS RESEARCH

Primary Culture,identification and in Vitro Angiogenesis of Mouse Pulmonary Microvascular Endothelial Cells

In Vitro and in Vivo Angiogenic Capacity Analysis on Different Clonal Endothelial Progenitor Cell Populations Derived from Human Circulating Blood

Construction of pcDNA3-Endo eukaryon expression plasmid and angiogenesis inhibition in vitro

Vascular endothelial growth factor on function of endothelial progenitor cells from peripheral blood

Perfusable Vessel-on-a-Chip for Antiangiogenic Drug Screening with Coaxial Bioprinting

Establishment of Experimental Angiogenic Models with Applications of Quantitative Digital Image Analysis

Thermo-sensitive Sacrificial Microsphere-based Bioink for Centimeter-scale Tissue with Angiogenesis

A Novel Tissue Model for Angiogenesis: Evaluation of Inhibitors or Promoters in Tissue Level

Cell-modified Bioprinted Microspheres for Vascular Regeneration

Angiogenesis and Functional Vessel Formation Induced by Interstitial Flow and Vascular Endothelial Growth Factor Using a Microfluidic Chip

Expression of Human Vascular Endothelial Growth Factor in Cultured NIH3T3 Cells

The Expression and angiogenesis Effect of VEGF gene

Progression of VEGF-targeted cancer therapy

Research Advance in Vascular Endothelial Growth Factor and Anti-Tumor

Angiogenic Synergistic Effect of Basic Fibroblast Growth Factor and Vascular Endothelial Growth Factor in an in Vitro Quantitative Microcarrier-Based Three-Dimensional Fibrin Angiogenesis System

Investigation of an Evaluative Experimental Scheme of Anti-angiogenic Therapy

Improvement of chick chorioallantoic membrane technique

Development and characterization of a chick embryo chorioallantoic membrane (CAM) based platform for evaluation of vasoactive medications

Replacement in angiogenesis research: Studying mechanisms of blood vessel development by animal-free in vitro, in vivo and in silico approaches

VEGF-A and FGF4 Engineered C2C12 Myoblasts and Angiogenesis in the Chick Chorioallantoic Membrane